Daniele Marinelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC). A systematic review and meta-analysis	BJUI COMPASS	2025
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma	NATURE MEDICINE	2025
A Response to the Letter to the Editor "Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?"	JOURNAL OF THORACIC ONCOLOGY	2025
Establishing survival benchmarks in the era of peri-operative immunotherapy	LUNG CANCER	2025
Abstract PR010: Linking proliferation rate to the evolution of single-cell primary and metastatic tumor clones	CANCER RESEARCH	2024
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study	THE ONCOLOGIST	2024
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis	BMC CANCER	2024
Prospective assessment of targeted symptom management on supportive care in cancer: An observational cohort study	JOURNAL OF CLINICAL ONCOLOGY	2024
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition	ESMO OPEN	2024
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study	FRONTIERS IN ONCOLOGY	2024
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis	BMC CANCER	2024
Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis	CURRENT ONCOLOGY	2024
Transcriptional Phenocopies of Deleterious KEAP1 Mutations Correlate with Survival Outcomes in Lung Cancer Treated with Immunotherapy	CLINICAL CANCER RESEARCH	2024
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience	BMC CANCER	2024
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis	JOURNAL OF THORACIC ONCOLOGY	2024
Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER	NATURE GENETICS	2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors	ANNALS OF ONCOLOGY	2024
86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma	JOURNAL OF THORACIC ONCOLOGY	2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma	LUNG CANCER	2023
Palliative sedation and time to death in home palliative care: retrospective analysis	BMJ SUPPORTIVE & PALLIATIVE CARE	2023

ERC

LS4_12

KET

Big data & computing
Life-science technologies & biotechnologies

Keywords

Non-small cell lung cancer (NSCLC)

cancer genomics